COVID-19 testing products and services

Collection Kits (MTM and VTM)
Rapid Antigen Tests
Rapid Antibody Tests
Compact XL “Lab in a Box
Goliath Platform

AccelBio - MyLab Partnership

Currently, we are offering four major supply solutions for COVID-19:

  • Collection Kits (MTM and VTM)
  • Rapid Antigen Tests
  • Rapid Antibody Tests
  • Lab in a Box: Compact XL for rapid RT-PCR, a medium-throughput platform
The details of these kits can be found in the brochures. We at AccelBio are delighted to discuss the specific needs of your organization and how we can deliver a solution of high quality.
AccelBio has partnered with MyLab Discovery Solutions to deliver multiple diagnostic solutions for COVID-19 testing.
We are able to supply companies, governments and institutions with sustained orders over the life cycle of their medical and diagnostic care programs - no demand is too large.

Collection Kits (MTM and VTM)

molecular
cellular
biochemistry
RNA biology
sub-cellular imaging
high-resolution imaging
molecular
cellular
biochemistry
RNA biology
sub-cellular imaging
high-resolution imaging

ViroTrap Molecular Transport Medium (MTM) designed and optimised for inactivation of infectious viruses, bacteria and fungal, pathogens with preserving DNA and RNA in the specimen.

The major difference in Viral Transport Media (VTM) and Molecular Transport Medium (MTM) is that VTM is designed to maintain viral viability and transport the specimen in it's active form.
In contrast, ViroTrap Molecular Transport Medium (MTM) is optimized specifically for molecular testing by inactivating pathogens and preserving the DNA and RNA of the sample.

Features

ViroTrap MTM is designed to:

  • Obtain high quality nucleic acids (DNA/RNA) from clinical or environmental samples.

  • Inactivate potentially infectious biological pathogens for safe handling and transport.

  • Stabilize released 'naked'DNA/RNA for prolonged periods without oxidative/hydrolysis/nuclease degradation.

  • Remove the requirement for cold chain during transport - sample is stabile at ambient temperature.

Get the brochure

Rapid Antigen Tests

PathoCatch COVID-19 Antigen Lateral Flow Test Device is a lateral flow immunoassay intended for in vitro qualitative detection of Nucleocapsid protein antigen from SARS-CoV-2 in nasal swab specimens from individuals who are suspected of COVID-19.

These lateral flow tests are CE marked in Europe (pending FDA approval) for 15 minute determination of COVID-19 human carrier using nasal swab.
They are simple to use and can be administered by a healthcare provider (HCP) with very little procedural manipulation required.
Get the brochure #1
Get the brochure #2

Rapid Antibody Tests

PathoCatch SARS-CoV-2 NAb Lateral Flow Test is an immune-chromatographic assay kit for the qualitative detection of SARS-CoV-2 neutralizing antibody in human serum/plasma.

Antibody tests take 10 minutes for determination of human exposure to COVID-19 or having received vaccination using a finger-prick blood drop.
They are simple to use and can be administered by a healthcare provider (HCP) with very little procedural manipulation required.
Get the brochure

Integrated sample controls yield validated results

By utilizing several internal nucleic acid controls through sample processing and molecular amplification, our processes are verified at each step to reduce false negatives and validate the result for each sample

Lab in a Box: Compact XL for rapid RT-PCR, a medium-throughput platform

The CompactXL is a fully-automated, 32 channel dual-deck molecular liquid handling platform with LIMS connectivity, for use in clinics, hospitals, and all diagnostic laboratories world-wide.
The CompactXL provides rapid, low-cost and highly accurate robotics for many diagnostic assays (in addition to COVID-19) in a portable, small box footprint.

AccelBio Proprietary Mass-scale Rapid PCR Platform

The molecular testing has specificity and sensitivity over 99%. This method is the “golden standard” for viral diagnostics.
This platform has been requested by several governments across the globe, and can be delivered, assembled and validated for use within several weeks.
Our partnership with the Ministry of Health in the Kingdom of Bahrain has demonstrated that this platform can test a complete population multiple-times — over five million (5 Million) PCR tests using this system has been performed in under a year.
In addition, AccelBio has developed proprietary testing platforms for large-scale diagnostic testing.
The Goliath Platform is a SINGLE PLATFORM that TESTS TENS OF THOUSANDS OF PATIENT SAMPLES IN A DAY.
AccelBio has launched a commercial offering of a turn-key, high-throughput rapid SARS-CoV-2 Virus molecular testing platform, which has been validated at AccelBio in the USA.
WE HAVE PIONEERED ROBOTIC TESTING AND CREATED SINGLE PLATFORMS THAT TEST TENS OF THOUSANDS OF PATIENT SAMPLES IN A DAY
Get the brochure

Fastest High-Throughput Molecular COVID-19 Detection System in the World

Pooled and Individual testing with Superior Specificity and Sensitivity

The Goliath Platforms are unique, scientifically-tested and validated instrument systems for rapid, high-throughput viral RNA detection, custom made specifically for COVID-19 testing.

Rapid high-throughput viral diagnostic
Analysis of ~400 samples for SARS-CoV-2 in under 2 hours
Get the brochure
SHARE

Most recently, we created a rapid high throughput Coronavirus detection platform in the Middle East, where processing and detection times were reduced by over 5-fold and error rates were reduced by over 85% on average.
‍
This was achieved through custom development of an automated robotic RNA extraction workstation coupled to a sensitive qRT-PCR system.

We provide rapid deployment of diagnostic testing through:

Procurement of top-line equipment from US life science equipment manufacturers

Arrangement for transport, installation, calibration, validation within 2 weeks

Training on equipment operation and interpretation of diagnostic results

Consumables purchasing with prioritization within verified supply channels

*make please these 4 paragraphs items as boxes(similar you designed for Hero)

We provide rapid deployment of diagnostic testing through:

Procurement of top-line equipment from US life science equipment manufacturers

Arrangement for transport, installation, calibration, validation within 2 weeks

Training on equipment operation and interpretation of diagnostic results

Consumables purchasing with prioritization within verified supply channels

Robotic liquid handling systems for rapid workflow

  • MINIMIZE HUMAN ERRORS
  • ACCELERATE TIME TO RESULTS
  • MINIMIZE STAFF REQUIREMENTS
The Platforms are almost completely automated, which is a distinct difference from other testing systems employed globally, operated by minimal personnel input which maximizes output, while diminishing the potential for inaccurate results due to human error.
The Goliath Platforms utilize state-of-the-art liquid handling robots manufactured in the USA.

Guaranteed superior quality reagent supply chain

The Platforms utilize FDA EUA-certified reagents and instruments to yield the highest accuracy within the industry, at 100% sensitivity and 100% specificity for all tests. These tests represent the “Golden Standard” for viral detection, utilizing PCR analysis of SARS-CoV-2 RNA extracted from human samples.
AccelBio has contracted with the largest US life science corporations to get significantly reduced pricing for instruments and millions of test reagents over the last few months, passing this discount down to their clients. AccelBio guarantees a continued supply of reagents and disposables for use on the Platform throughout the life of the testing capacity.

Rapid Deployment

Improved detection

AccelBio has optimized the simultaneous detection of SARS-CoV-2 and influenza

Explore Our solutions

The detection of numerous viral pathogens simultaneously will enable the rapid identification of infected individuals, accelerate their treatment, and minimize the spread of disease

COVID-19 testing:
what to know about your assays and reagents

Not All Viral Transport Media Are Made Alike: Reported Problems with Kits from China

UW Medicine halts use of coronavirus testing kits airlifted from China after some had contamination

Read more on:
The Seattle Times

CDC Highlights Updates to Collection and Handling of Clinical Specimens for COVID-19 Use and Determination

Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens for COVID-19

Read on:
CDC

ThermoFisher Scientific COVID-19 Combo Kit Receives Broader FDA-EUA Approval For Use in WorkFlow

FDA Further Expands EUA for Thermo Fisher Scientific's COVID-19 Diagnostic Tests

Read on:
Cision

Not All Viral Transport Media Are Made Alike: Reported Problems with Kits from China

UW Medicine halts use of coronavirus testing kits airlifted from China after some had contamination

Read more on:
The Seattle Times

CDC Highlights Updates to Collection and Handling of Clinical Specimens for COVID-19 Use and Determination

Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens for COVID-19

Read on:
CDC

ThermoFisher Scientific COVID-19 Combo Kit Receives Broader FDA-EUA Approval For Use in WorkFlow

FDA Further Expands EUA for Thermo Fisher Scientific's COVID-19 Diagnostic Tests

Read on:
Cision
What are your testing needs?
Please fill out the form and we will contact you within 24 hours
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
AboutCareersContactPolicy & Terms
COVID-19 Testing ProductsPrimary and Transgenic Cell providersHigh-Throughput Drug ScreeningCustom Neuroscience / RNA Biology AssaysAccelBio Covid Testing Services (ABTS)Custom services
Products
Services
Customer support